Cargando…

Current impact of viral hepatitis on liver cancer development: The challenge remains

Chronic infections due to hepatitis B and hepatitis C viruses are responsible for most cases of hepatocellular carcinoma (HCC) worldwide, and this association is likely to remain during the next decade. Moreover, viral hepatitis-related HCC imposes an important burden on public health in terms of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mattos, Ângelo Zambam, Debes, Jose D, Boonstra, Andre, Yang, Ju-Dong, Balderramo, Domingo C, Sartori, Giovana D P, de Mattos, Angelo Alves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240060/ https://www.ncbi.nlm.nih.gov/pubmed/34239269 http://dx.doi.org/10.3748/wjg.v27.i24.3556

Ejemplares similares

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Albumin administration in patients with cirrhosis: Current role and novel perspectives
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2022)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2021)

Impact of multidrug resistance on the management of bacterial infections in cirrhosis
por: Terra, Carlos, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
por: Balderramo, Domingo
Publicado: (2022)

Nutritional evaluation in cirrhosis: Emphasis on the phase angle
por: Fernandes, Sabrina Alves, et al.
Publicado: (2016)

MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023)

To: The economic effect of extracorporeal membrane oxygenation to support adults with severe respiratory failure in Brazil: a hypothetical analysis
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2015)

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
por: Coelho, Marta Paula Pereira, et al.
Publicado: (2023)

Remaining issues of recommended management in current guidelines for asymptomatic common bile duct stones
por: Saito, Hirokazu, et al.
Publicado: (2021)

Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients
por: Picon, Rafael Veiga, et al.
Publicado: (2017)

The Eukaryotic Ribosome: Current Status and Challenges
por: Dinman, Jonathan D.
Publicado: (2009)

Viral hepatitis: Innovations and expectations
por: Leoni, Simona, et al.
Publicado: (2022)

Helicobacter pylori in ancient human remains
por: Maixner, Frank, et al.
Publicado: (2019)

Update on the management and treatment of viral hepatitis
por: Almeida, Patricia Holanda, et al.
Publicado: (2021)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Update on global epidemiology of viral hepatitis and preventive strategies
por: Jefferies, Meryem, et al.
Publicado: (2018)

LIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS
por: CORAL, Gabriela P., et al.
Publicado: (2016)

PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
por: Leathers, James S, et al.
Publicado: (2018)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Autoimmune hepatitis: Appraisal of current treatment guidelines
por: Lowe, Dhruv, et al.
Publicado: (2018)

Current evidence on the management of hepatitis B in pregnancy
por: Maraolo, Alberto Enrico, et al.
Publicado: (2018)

Era of direct acting anti-viral agents for the treatment of hepatitis C
por: Ahmed, Monjur
Publicado: (2018)

Hepatitis of unknown etiology in children: Current evidence and association
por: Zhong, Rui, et al.
Publicado: (2022)

Challenges in the discontinuation of chronic hepatitis B antiviral agents
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history
por: Sarma, Moinak Sen, et al.
Publicado: (2022)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice
por: Ferrarese, Alberto, et al.
Publicado: (2021)

Chronic hepatitis B in pregnant women: Current trends and approaches
por: Belopolskaya, Maria, et al.
Publicado: (2021)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
por: Wang, Di, et al.
Publicado: (2023)

Potential Applications of Human Viral Metagenomics and Reference Materials: Considerations for Current and Future Viruses
por: Santiago-Rodriguez, Tasha M., et al.
Publicado: (2020)

Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
por: Moran, Segundo, et al.
Publicado: (2021)

Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia
por: Ielasi, Luca, et al.
Publicado: (2023)

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o797kq3foi0amail5n9n252cib